Reuters logo
BRIEF-Pulmatrix and Mylan collaborate for pilot pharmacokinetic clinical study
July 19, 2016 / 1:15 PM / a year ago

BRIEF-Pulmatrix and Mylan collaborate for pilot pharmacokinetic clinical study

July 19 (Reuters) - Pulmatrix Inc

* Pulmatrix led pilot pharmacokinetic clinical study and supportive development work with collaborative support from Mylan

* Financial terms of agreement are confidential

* Announced positive topline data from a phase 1 pilot pharmacokinetic bioavailability trial of PUR0200

* Mylan has retained an option for PUR0200 EX-U.S. rights based on successful completion of clinical study Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below